The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
AstraZeneca Pharmaceuticals
AstraZeneca has completed a previously communicated agreement to recover the global rights to brazikumab, a monoclonal antibody targeting IL23, from ...
read more
U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Protagonist Therapeutics announced initial data from the ongoing Phase 2 study of PTG-300 in patients with polycythemia vera.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Enlivex announced an investigator-initiated multi-center Phase II clinical trial of Allocetra in COVID-19 patients has commenced.
read more
Wize Pharma has completed treating patients in its Phase IV clinical trial of LO2A, for dry eye syndrome in patients with Sjögren's syndrome.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
The University of Oxford and SPI announced the successful completion of a Phase 2a study testing SPI-1005 as a new treatment for bipolar disorder.
read more
OSE Immunotherapeutics announced its team of immunologists is actively working on the development of a prophylactic vaccine against the pandemic virus...
read more
Evelo , Rutgers, and RWJ announced the submission of an IND application for a clinical study of EDP1815 for newly diagnosed COVID-19.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Santhera announces the signing of two agreements with Rutgers as part of its program to advance gene therapy research for the treatment of LAMA2-...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Janssen Research & Development
Halozyme announced Janssen Biotech has received approval from the FDA for DARZALEX FASPRO.
read more